MILTON — The Milton School District has established a new three-year pathway for students interested in pursuing a career in health care or a related field. “This program,” Andrew Rantz, district ...

GEORGE COUNTY, Miss. (WLOX) - Four inmates at the George County Regional Correctional Facility graduated from educational programs through Mississippi Gulf Coast Community College. Two inmates ...

The Pascagoula-Gautier School Board unanimously approved the hiring of Zach Green to lead the Panthers, making him the 34th head coach in school history. The two Coast students will be part of a group ...

The latest quarter-point cut will reduce the Fed’s benchmark short-term interest rate to a range between 3.75% and 4%, the lowest setting in three years and down from a peak of around 5.4% that the ...

“The Salt Path Scandal” is filled with “tasty nuggets”, said Carol Midgley in The Times. Sky’s documentary follows journalist Chloe Hadjimatheou as she delves into the alleged lies and deceit behind ...

HIV and tuberculosis (TB) treatment programs have always relied on clinical trials to understand whether treatment interventions are actually working, but they're costly and cumbersome. Meanwhile, ...

UiPath Inc. (PATH) is one of a bunch of software companies that went public in 2021, saw its shares subsequently collapse, and have seemingly never managed to make a recovery. And to be fair, many of ...

BigBear.ai Holdings, Inc. BBAI is entering a pivotal phase as it deepens its commitment to edge-ready, mission-grade AI for national security. The company’s third-quarter 2025 results highlight ...

Blue Origin’s New Glenn lifts off on the NG-2 mission Nov. 13. Credit: Blue Origin ORLANDO, Fla. — Blue Origin’s New Glenn rocket will have to complete four successful orbital flights as its pathway ...

RPG Path of Exile 2 players suffer the consequences of dealing illegal amounts of damage as boss shrugs off a 95M-damage hit RPG Larian's learnt a lot from Baldur's Gate 3 going into Divinity, ...

Encoded Therapeutics has linked its Dravet syndrome gene therapy ETX101 to a 78% reduction in seizures, keeping the biotech on track to start a pivotal study next year. The Californian company’s ...